MedTek21

MedTek21 is a real-time precision medicine and medication risk management platform that specializes in pharmacogenomics (PGx) to enhance patient safety. The company's cloud-based software integrates with electronic health records (EHR) to provide clinicians with actionable insights into drug-gene and drug-drug interactions. By identifying high-risk patients and providing point-of-care clinical decision support, MedTek21 helps healthcare providers proactively manage polypharmacy and reduce adverse drug events. The platform is widely used by health systems, long-term care facilities, and payers to optimize therapeutic outcomes and lower care costs. Following its acquisition by AccessDX Holdings, MedTek21 continues to expand its capabilities in population health and diagnostic-based analytics.